Skip to main content
Have a personal or library account? Click to login
An adjustment of vancomycin dosing regimen for a young patient with augmented renal clearance: A case report / Úprava dávkového režimu vankomycínu pre mladého pacienta so zvýšeným renálnym klírensom: Kazuistika Cover

An adjustment of vancomycin dosing regimen for a young patient with augmented renal clearance: A case report / Úprava dávkového režimu vankomycínu pre mladého pacienta so zvýšeným renálnym klírensom: Kazuistika

European Pharmaceutical Journal
Volume 62 (2015): Issue 2 (December 2015)
By: ,  ,  ,   and    
Open Access
|Dec 2015
References

References

  1. [1] Babtista JP, Sousa E, Martins PJ, Pimentel JM. Augmented renal clearance in septic patients and implications for vancomycin optimisation. Int J Antimicrob Agents. 2012;39(12): 420-23.
    Open DOISearch in Google Scholar
  2. [2] Minkutė R, Briedis V, Steponavičiūtė R, Vitkauskienė A, Mačiulaitis R. Augmented renal clearance - an evolving risk factor to consider during the treatment with vancomycin. J Clin Pharm Ther. 2013;38(6):462-67.
    Open DOISearch in Google Scholar
  3. [3] Udy AA, Roberts JA, Lipman J. Implications of augmented renal clearance in critically ill patients. Nat Rev Nephrol. 2011;7(9):539-43.
    Open DOISearch in Google Scholar
  4. [4] Campassi ML, Gonzalez MC, Masevicius FD, Vazquez AR, Moseinco M, Navarro NC et al. Augmented renal clearance in critically ill patients: incidence, associated factors and effects on vancomycin treatment. Rev Bras Ter Intensiva. 2014;26(1):13-20.
    Open DOISearch in Google Scholar
  5. [5] Udy A, Roberts JA, Lipman J. Clinical implications of antibiotic pharmacokinetic principles in the critically ill. Intensive Care Med. 2013;39(12):2070-82.
    Open DOISearch in Google Scholar
  6. [6] Baptista JP, Udy AA, Sousa E, Pimentel J, Wang L, Roberts JA, Lipman J. A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance. Crit Care. 2011;15(3):R139.
    Open DOISearch in Google Scholar
  7. [7] Cook AM, Arora S, Davis J, Pittman T. Augmented renal clearance of vancomycin and levetiracetam in a traumatic brain injury patient. Neurocrit Care. 2013;19(2):210-14.
    Open DOISearch in Google Scholar
  8. [8] Udy A,Boots R, Senthuran S, Stuart J, Deans R, Lassig-Smith M, Lipman J. Augmented creatinine clearance in traumatic brain injury. Anesth Analg. 2010;111(6):1505-10.
    Open DOISearch in Google Scholar
  9. [9] Udy AA, Roberts JA, Boots RJ, Paterson DL, Lipman J. Augmented renal clearance: Implications for antibacterial dosing in the critically ill. Clin Pharmacokinet. 2010; 49(1):1-16.
    Open DOISearch in Google Scholar
  10. [10] Udy AA, Roberts JA, Shorr AF, Boots RJ, Lipman J. Augmented renal clearance in septic and traumatized patients with normal plasma at-risk patients creatinine concentrations: identifying atrisk patients. Critical Care. 2013;17:R35.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/afpuc-2015-0025 | Journal eISSN: 2453-6725 (formerly 1338-6786) | Journal ISSN: 0301-2298
Journal RSS Feed
Language: English
Page range: 1 - 4
Submitted on: Sep 16, 2015
Accepted on: Oct 15, 2015
Published on: Dec 31, 2015
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Keywords:
Vancomycin,
Augmented renal clearance (ARC),
Therapeutic drug monitoring (TDM)
Related subjects:
Pharmacy,
Pharmacy, other

© 2015 Maria Goboova, Magdalena Kuzelova, Viera Kissova, Dasa Bodakova, Elena Martisova, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 62 (2015): Issue 2 (December 2015)
Next article